NVIDIA AI Podcast cover image

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

NVIDIA AI Podcast

00:00

Machine Learning to Map the Immune System

So how much of the work that immuniis doing is a involves synthetic data, as opposed togess biological data. We really believe that synthetic data would be a big part of the future of the f computational methods,. But right now we actually do not rely very taa on synthetic data. So this is, and the bing reason for that is because i think we leet still much more data and much more understanding around like the biasis. The data to be with wic to generate a trustwor infate. That's what amuno therapy is in the rollin and finding and developing new therapeutics.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner